Otsuka Holdings Co., Ltd. (FRA:OS1)
Germany · Delayed Price · Currency is EUR 37.80
-0.60 (-1.56%)
At close: Jul 18, 2025, 10:00 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Pharmaceuticals | 1,629.03B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Growth | 17.07% | Log In | Log In | Log In | Log In | Upgrade |
Nutraceuticals | 557.01B | Log In | Log In | Log In | Log In | Upgrade |
Nutraceuticals Growth | 11.19% | Log In | Log In | Log In | Log In | Upgrade |
Consumer Products | 33.75B | Log In | Log In | Log In | Log In | Upgrade |
Consumer Products Growth | -6.24% | Log In | Log In | Log In | Log In | Upgrade |
Other Segment | 110.07B | Log In | Log In | Log In | Log In | Upgrade |
Other Segment Growth | 2.91% | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 1.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | 92.43B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -37.86% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Segment Profit | 285.11B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Segment Profit Growth | 114.82% | Log In | Log In | Log In | Log In | Upgrade |
Nutraceuticals Segment Profit | 59.78B | Log In | Log In | Log In | Log In | Upgrade |
Nutraceuticals Segment Profit Growth | 45.46% | Log In | Log In | Log In | Log In | Upgrade |
Consumer Products Segment Profit | 23.00B | Log In | Log In | Log In | Log In | Upgrade |
Consumer Products Segment Profit Growth | 67.84% | Log In | Log In | Log In | Log In | Upgrade |
Other Segment Profit | 7.53B | Log In | Log In | Log In | Log In | Upgrade |
Other Segment Profit Growth | -883.09% | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Segment Profit | -51.85B | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Segment Profit Growth | 14.94% | Log In | Log In | Log In | Log In | Upgrade |
Other | 92.43B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -37.86% | Log In | Log In | Log In | Log In | Upgrade |
Other | 92.43B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -37.86% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Japan | 699.70B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | 2.38% | Log In | Log In | Log In | Log In | Upgrade |
North America | 1,095.10B | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | 25.20% | Log In | Log In | Log In | Log In | Upgrade |
Europe | 242.90B | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | 10.79% | Log In | Log In | Log In | Log In | Upgrade |
Others | 292.20B | Log In | Log In | Log In | Log In | Upgrade |
Others Growth | 11.74% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Pharmaceuticals Business Profit | 390.61B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Business Profit Growth | 46.63% | Log In | Log In | Log In | Log In | Upgrade |
Nutraceuticals Business Profit | 64.15B | Log In | Log In | Log In | Log In | Upgrade |
Nutraceuticals Business Profit Growth | -10.90% | Log In | Log In | Log In | Log In | Upgrade |
Consumer Products Business Profit | 23.66B | Log In | Log In | Log In | Log In | Upgrade |
Consumer Products Business Profit Growth | 10.96% | Log In | Log In | Log In | Log In | Upgrade |
Other Segment Business Profit | 6.95B | Log In | Log In | Log In | Log In | Upgrade |
Other Segment Business Profit Growth | -7.00% | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Business Profit | -54.91B | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Business Profit Growth | 11.80% | Log In | Log In | Log In | Log In | Upgrade |